# A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

> **NCT00961025** · PHASE1 · UNKNOWN · sponsor: **Dong-A Pharmaceutical Co., Ltd.** · enrollment: 110 (estimated)

## Conditions studied

- Diabetes Mellitis Type 2

## Interventions

- **DRUG:** DA-1229
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00961025
- **Lead sponsor:** Dong-A Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2009-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961025, "A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00961025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*